Rare disease patients in India are facing a funding crisis after exhausting the financial assistance available under the National Policy for Rare Diseases (NPRD), 2021.
The Lysosomal Storage Disorders Support Society (LSDSS) has written to Prime Minister Narendra Modi seeking an interim funding mechanism to restore treatment for these patients.
Key Takeaways
- Rare disease patients in India are facing a funding crisis after exhausting financial assistance under NPRD, 2021.
- The LSDSS is seeking an interim funding mechanism to restore treatment for these patients.
- Children and patients at high clinical risk must be prioritised for treatment.
Who is affected by the funding crisis?
Patient groups, including those suffering from ultra-rare Lysosomal Storage Disorders (LSDs) such as Gaucher and Pompe disease, are affected.
Many of these patients are children as young as two, three, four or five years of age.
What the 50 lakh cap changes for patients
The 50 lakh financial assistance available under NPRD, 2021, is often insufficient for patients requiring lifelong or long-term therapy.
Around 164 patients have exhausted this financial assistance, with 115 of them suffering from ultra-rare LSDs.
By the numbers
- 164 patients have exhausted the financial assistance available under NPRD, 2021.
- 115 patients are suffering from ultra-rare LSDs, including Gaucher and Pompe disease.
- 50 lakh is the financial assistance available under NPRD, 2021, which is often insufficient for patients requiring lifelong or long-term therapy.
What the LSDSS is recommending
The LSDSS is urging the Ministry to provide funding on a case-to-case basis through the existing NPRD mechanisms.
It is also recommending that a continuity-of-treatment mechanism be established under NPRD to fill a structural gap in the implementation of the policy.
Next steps for rare disease patients
The LSDSS is seeking urgent intervention from the Prime Minister and the Union Health Minister to reinstate treatment for all clinically eligible patients.
Children and patients at high clinical risk must be prioritised for treatment, and all concerned Centres of Excellence must be directed to identify and report such patients immediately.
Background of the National Policy for Rare Diseases
The National Policy for Rare Diseases (NPRD), 2021, was launched to provide financial assistance to patients with rare diseases.
However, the policy has been facing challenges in its implementation, including the limited financial assistance available to patients.
Read also: Alzheimer's Resistance Explained
Read also: COVID-19 taste loss causes and effects
Implications for rare disease patients in India
The funding crisis faced by rare disease patients in India has significant implications for their health and well-being.
Without access to timely and effective treatment, patients with rare diseases may experience a decline in their health, leading to increased morbidity and mortality.
Expert perspective on rare disease treatment
Experts in the field of rare diseases have emphasized the need for a comprehensive and sustainable funding mechanism to support patients with rare diseases.
They have also highlighted the importance of prioritizing children and patients at high clinical risk for treatment.
Timeline of the funding crisis
The funding crisis for rare disease patients in India has been ongoing, with patients exhausting their financial assistance under NPRD, 2021, over the past year.
The LSDSS has been advocating for an interim funding mechanism to restore treatment for these patients.
What to watch next
The response of the Prime Minister and the Union Health Minister to the LSDSS's appeal will be crucial in determining the next steps for rare disease patients in India.
The establishment of a continuity-of-treatment mechanism under NPRD and the provision of funding on a case-to-case basis will be key to addressing the funding crisis faced by these patients.
Frequently Asked Questions
What is the National Policy for Rare Diseases (NPRD), 2021?
The NPRD, 2021, is a policy launched to provide financial assistance to patients with rare diseases in India.
How many patients have exhausted the financial assistance available under NPRD, 2021?
Around 164 patients have exhausted the financial assistance available under NPRD, 2021.
What is the LSDSS recommending to address the funding crisis?
The LSDSS is recommending that the Ministry provide funding on a case-to-case basis through the existing NPRD mechanisms and establish a continuity-of-treatment mechanism under NPRD.
